ATORVASTATIN CALCIUM
NDC 70518-0186, ATORVASTATIN CALCIUM, tablet, film coated, from REMEDYREPACK INC..
- Product NDC
- 70518-0186
- Status
- Listed
- Labeler
- REMEDYREPACK INC.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090548
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70518-0186 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE20 mg/1
Pharmacologic classes
HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70518-0186-0 | 70518018600 | 30 TABLET, FILM COATED in 1 BLISTER PACK (70518-0186-0) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e91c673d-c26c-4ff1-90d2-2b9d47a8d771
Use it
Look up 70518-0186 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70518-0186 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70518-0186. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.